||Yang, Hai-Tao; Xie, Xiang; Hou, Xian-Geng; Xiu, Wen-Juan; Wu, Ting-Ting.|
||Cardiac shock wave therapy for coronary heart disease: an updated meta-analysis|
||Rev. bras. cir. cardiovasc = Braz. j. cardiovasc. surg. (impr.);35(5):741-756, Sept.-Oct. 2020. tab, graf.
||Tianshan Xuesong Project; . Xinjiang Science and Technology Aid Project.
||Abstract Introduction: The aim of this article is to study the efficacy and safety of cardiac shock wave therapy (CSWT) in the treatment of coronary heart disease (CAD). Methods: A comprehensive search of electronic databases and a manual search of conference papers and abstracts were performed until September 30, 2018. The studies using RevMan 5.3 and STATA 14.0 softwares were reviewed, and meta-analyses were performed on 13 indicators, such as a six-min walking distance test (6MWT), New York Heart Association (NYHA) functional class, Seattle Angina Questionnaire (SAQ) score, angina class (Canadian Cardiology Society [CCS]), etc. Results: A total of 26 articles were included. The total patient population was 855, of which 781 patients were treated with CSWT. Meta-analyses indicated that 6MWT (mean difference [MD] 75.64, 95% confidence interval [CI] 49.03, 102.25, P<0.00001) and NYHA (MD -0.70, 95% CI -0.92) in the CSWT group were comparable to those in the conventional revascularization group (MD -0.70, 95% CI -0.92, -0.49, P<0.00001). SAQ (MD 10.75, 95% CI 6.66, 14.83, P<0.00001), CCS (MD -0.99, 95% CI -1.13, -0.84, P<0.00001), nitrate dosage (MD -1.84, 95% CI -2.77, -1.12, P<0.00001), LVEF (MD 3.77, 95% CI 2.17, 5.37, P<0.00001), and SSS (MD -4.29, 95% CI -5.61, -2.96, P<0.00001), SRS (MD -2.90, 95% CI -4.85, -0.95, P=0.004), and the exercise test (standard mean difference 0.57, 95% CI 0.12, 1.02, P=0.01) all showed significant differences. Conclusion: CSWT may offer beneficial effects to patients with CAD, but more large-scale clinical studies are needed to further verify its therapeutic effect.|
||Doença das Coronárias/terapia|
Tratamento por Ondas de Choque Extracorpóreas
Inibidores da Enzima Conversora de Angiotensina
Estudos de Coortes
Resultado do Tratamento
Ondas de Choque de Alta Energia
Antagonistas de Receptores de Angiotensina
Intervenção Coronária Percutânea
| Tipo de Publ:
||Research Support, Non-U.S. Gov't|
||BR1.1 - BIREME|